Skip to main content
OpenTrials
Completed

NCT Number: NCT02523729

Effects of Anke Malz on Women During Lactation

Human milk is the most optimal food to provide all infants' needs before eating solid food. However, underproduction of milk is a common and concerned problem for breastfeeding women. In this case, proper milk-making foods reveal their importance on lactation. In many European countries, ancient wisdom clams that non-alcoholic malt beverage could facilitate the secretion of breast milk. This study estimates the effects of non-alcoholic malt product during first three months of lactation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Single fetal pregnancy
  • Full time birth

Exclusion criteria

  • Any complication during pregnancy
  • Smokers
  • Alcohol or drug abuse

Treatment and study plan

Anke Malz

Dietary Supplement

non-alcoholic malt drink

Primary outcomes

  1. The concentration of prolactin on lactational women

    Time frame: three months

Secondary outcomes

  1. Mean breast-feeding time

    Time frame: three months

Sponsors and collaborators

Lead sponsor

China Medical University Hospital

Other

Collaborators

  • Lorillard Tobacco Company

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Aug 14, 2015
Registry last updated
Aug 14, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.